Clinical Trials in San Francisco

Showing 2241-2260 of 6,211 trials

A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

NCT03822871

The purpose of this study is to find the highest dose level of study drug, CTT1403, that can be safely administered to patients with metastatic castration resistant prostate cancer (mCRPC).

Prostate Cancer

Cancer Targeted Technology17 participantsStarted Apr 2019

San Francisco, California, United States

COMPLETEDPhase 3< 1 mile

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

NCT00003782

RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die. Giving combination chemotherapy after surgery may kill any tumor cells remaining following surgery. It is not yet known which regimen of combination chemotherapy is more effective in treating breast cancer with positive axillary lymph nodes. PURPOSE: Randomized phase III trial to compare the effectiveness of different regimens of combination chemotherapy in treating women who have undergone surgery for stage I, stage II, or stage IIIA breast cancer with positive axillary lymph nodes.

Breast Cancer

NSABP Foundation Inc5,351 participantsStarted Mar 1999

Huntsville, Alabama, United States • Anchorage, Alaska, United States • Phoenix, Arizona, United States +154 more locations

A Trial of CTT1403 for Metastatic Castration Resistant Prostate Cancer

Combination Chemotherapy in Treating Women With Stage I, Stage II, or Stage IIIA (cT1-3, N0-1, M0) Breast Cancer and Positive Axillary Lymph Nodes

Find Trials by Condition in San Francisco

Efficacy and Safety Study of ME1111 in Patients With Onychomycosis

Tagraxofusp to Eradicate Measurable Residual Disease in Patients With Acute Myeloid Leukemia

A Study on Patients With Chronic Kidney Disease (CKD) to Assess Treatment Experience and Patterns, Effect of the Treatment, Patient Outcomes and Patient Quality of Life

Investigative Analysis of Soft Tissue Sarcoma Clinical Trials: An Observational Study

OCS Lung System EXPAND II Trial

HCV-TARGET- Hepatitis C Therapeutic Registry and Research Network

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 in Gastric/Gastroesophageal Cancer

A Study of Bemarituzumab (FPA144) Combined With Modified FOLFOX6 (mFOLFOX6) in Gastric/Gastroesophageal Junction Cancer

Effects of Sugary Drinks Counter-marketing Messages

Feasibility of Text4US Program

A Study to Compare Safety and Efficacy of Upadacitinib to Dupilumab in Adult Participants With Moderate to Severe Atopic Dermatitis

Multi-center Phase I/IIa Trial of an Autologous Tumor Lysate (TL) + Yeast Cell Wall Particles (YCWP) + Dendritic Cells (DC) Vaccine in Addition to Standard of Care Checkpoint Inhibitor of Choice in Metastatic Melanoma Patients With Measurable Disease.

Avelumab in Participants With Merkel Cell Carcinoma (JAVELIN Merkel 200)

Study to Assess Epidural Resiniferatoxin for the Treatment of Intractable Pain Associated With Advanced Cancer

PTX-35 in Patients With Advanced Solid Tumors

A Study to Compare Bempegaldesleukin (BEMPEG: NKTR-214) Combined With Nivolumab and Tyrosine Kinase Inhibitor (TKI) to Nivolumab and TKI Alone in Participants With Previously Untreated Kidney Cancer That is Advanced or Has Spread

Evaluating the Safety, Pharmacokinetics, and Anti-Viral Activity of VRC01 and VRC01LS in the Serum and Mucosa of Healthy, HIV-Uninfected Adults

HPV Vaccine Therapy in Interrupting Progression in Patients With High-Grade Vulvar or Anal Lesions